Provenge, Cancer Drug, Costs $93,000: Sky High Drug Prices Impact Life-Or-Death Decisions
Sunday, September 26, 2010
US taxpayers have already paid for these drugs through taxpayer-subsidized research, which was originally sold to the American people as an investment in lowering prices down the road (we would basically share the profits and be partners with the pharmaceutical companies that have profited financially from drug patents).
To open up markets overseas, pharmaceutical companies sell drugs cheapy in foreign countries and have American subsidize the losses.
This is yet another example of both Republicans and the DLC-controlled Democratic Party selling the American people out. They do not work for us, on our behalf; they are corporate t00Is.
Read the Article at HuffingtonPost
0 comments:
Post a Comment